In non-small-cell lung cancer (NSCLC) A549 and H460 cells, cardamonin activated caspase-3, increased Bax levels, decreased Bcl-2 levels, thus inducing apoptosis [60]. The gene discussed is BCL2; the disease is non-small cell lung carcinoma.